Intrahepatic cholestasis of pregnancy (ICP) increases the risk of stillbirth, more often than not. Patients affected by ICP have a higher stillbirth probability when compared to patients without the condition. The stillbirth rate at 37 weeks gestation and beyond, for the entire population in the United States, is approximately 0.1% to 0.3%.